Bioavailability Enhancement Webinar Series - Nanoparticle Dispersions & Drug Nanocrystals

January 21, 2014 2014-01-21 00:00:00 2014-01-21 00:00:00 America/New_York Bioavailability Enhancement Webinar Series - Nanoparticle Dispersions & Drug Nanocrystals Please join us for our next bioavailability enhancement webinar on January 21, 2014, which will focus on nanotechnology advancements. 11:00 AM - 12:00 PM ET (17:00-18:00 CET)

11:00 AM - 12:00 PM ET (17:00-18:00 CET)

Market Segment: Pharmaceutical

Please join us for our next bioavailability enhancement webinar January 21, 2014, which will focus on nanotechnology advancements.

Drug-containing nanoparticles offer the potential for both increased dissolution rate and higher drug activity compared to bulk crystalline drug. These advantages can improve oral bioavailability of drugs for which absorption is either dissolution-rate-limited (i.e. DCS Class IIa), or solubility-limited (i.e., DCS Class IIb and IV drugs).  In this webinar, the physicochemical properties, in vitro and in vivo performance, and manufacturing considerations for amorphous nanoparticle dispersions and drug nanocrystals for bioavailability enhancement will be explored.

See this webinar here:

Bioavailability Enhancement Webinar Series - Amorphous Solid Dispersion Formulations Using The Spray Dry Process

November 21, 2013 2013-11-21 00:00:00 2013-11-21 00:00:00 America/New_York Bioavailability Enhancement Webinar Series - Amorphous Solid Dispersion Formulations Using The Spray Dry Process 11:00 AM - 12:00 PM EDT (16:00 - 17:00 CET)

11:00 AM - 12:00 PM EDT (16:00 - 17:00 CET)

Market Segment: Pharmaceutical

Capsugel’s Dosage Form Solutions (DFS) team is hosting a series of webinars covering the range technologies available for enabling improved bioavailability of new chemical entities or existing API’s. Join us for our upcoming live webinar devoted to spray-dried dispersion technology.

What:  Bioavailability Enhancement Series: Amorphous Solid Dispersion Formulation Using the Spray Dry Process 

Amorphous solid dispersion technology has been developed to be a preferred formulation option with a wide range of applicability for improving solubility and dissolution rate of insoluble compounds. When amorphous compounds are delivered orally, their solubility advantage can translate into significantly enhanced bioavailability. This webinar will discuss the application of amorphous solid dispersions via the spray drying process in preclinical formulation identification, including stability and performance considerations. Illustrative case studies will be presented.

When: Monday, November 21 at 11:00 AM-12:00 PM EDT

See this webinar here:

Vcaps Plus Capsules - a new high performance HPMC capsule for optimum formulation of pharmaceutical dosage forms

November 07, 2013 2013-11-07 00:00:00 2013-11-07 09:11:00 America/New_York Vcaps Plus Capsules - a new high performance HPMC capsule for optimum formulation of pharmaceutical dosage forms 11:00 AM - 12:00 PM EST (17:00-18:00 CET)

11:00 AM - 12:00 PM EST (17:00-18:00 CET)

Market Segment: Pharmaceutical

A new second generation HPMC capsule has been developed to speed formulation and commercialization timelines in pharmaceutical drug development. Vcaps Plus capsules developed without gelling agents provide HPMC capsules with improved physical and operational performance to match the needs of the pharmaceutical industry. This presentation will review the studies that demonstrate superior performance over traditional HPMC capsules and demonstrate how these capsules, now in use at many major pharmaceutical companies, can optimize product performance and improve product stability as well as reduce development timelines.

See this webinar here:

Technology Selection for Enhancing Bioavailability

October 30, 2013 2013-10-30 00:00:00 2013-10-30 00:00:00 America/New_York Technology Selection for Enhancing Bioavailability 11:00 AM - 12:00 PM EDT (16:00-17:00 CET)

11:00 AM - 12:00 PM EDT (16:00-17:00 CET)

Market Segment: Pharmaceutical

Compounds that require bioavailability enhancement to achieve target absorption are increasingly common in current pipelines.
Accordingly, these compounds are paired with various technologies to enable progression.

This presentation will focus on the rationale for selecting these enabling technologies based on compound’s physical properties (e.g., Tm, Tg, LogP) and product specifications (e.g., dose, pharmacokinetics, permeability).

Case studies will be presented that illustrate this process of technology and formulation selection based on the above descriptors.

See the webinar here:

Hot Topics in Dietary Supplements

October 16, 2013 2013-10-16 00:00:00 2013-10-16 00:00:00 America/New_York Hot Topics in Dietary Supplements 2:00 - 3:00 PM EST (20:00 - 21:00 CET)

2:00 - 3:00 PM EST (20:00 - 21:00 CET)

Market Segment: Dietary Supplement

Sales of dietary supplements continue to rise, reaching $11.5 billion in the U.S. alone in 2012, according to market researcher Packaged Facts. What issues do companies need to consider in order to navigate this market successfully? Join us October 16th for a discussion of some Hot Topics in Dietary Supplements.

AREAS OF INTEREST:

• New Human Clinical on Better Ways to Deliver Probiotics

• The Mounting Debate on Non-GMO Labeling
• Chromium Concerns & Impact on Supply Chain Security?

Speakers Include:
Mark Vieceli - Director Sales, Marketing & Business Development, Capsugel
Loren Israelsen - President, United Natural Products Alliance
Cliff Kendrick - Business Development Manager (Dietary Supplements), Capsugel

See the webinar here: